drugset / Trial / NCT01313819

The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy

NCT01313819

Phase 4 Unknown 20 enrolled Seoul National University Hospital
RandomizedCrossoverTriple-blindTreatment

Summary

Tp determine the effect of IV amantadine on dopaminergic-drug-resistant freezing of gait(FOG)in patients with Parkinson's disease

Timeline

Start
2011-04
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amantadine Unknown 200 mg Intravenous